Treatment of relapsed and refractory multiple myeloma-Reference-Cited by-同舟云学术

Treatment of relapsed and refractory multiple myeloma

Published:2003-06 Issue:3 Volume:4 Page:229-237
ISSN:1527-2729
Container-title:Current Treatment Options in Oncology
language:en
Short-container-title:Curr. Treat. Options in Oncol.

Author:

Singhal Seema,Mehta Jayesh

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11864-003-0024-9.pdf

Reference31 articles.

1. Singhal S: High-dose therapy and autologous transplantation. In Myeloma. Edited by Mehta J, Singhal S. London: Martin Dunitz; 2002:327–347.

2. Mehta J: Allogeneic hematopoietic stem cell transplantation in myeloma. In Myeloma. Edited by Mehta J, Singhal S. London: Martin Dunitz; 2002:349–365.

3. Powles R, Singhal S, Sirohi B, et al.: Discontinuous complete remission: a new endpoint to evaluate the success of therapy in keeping myeloma patients disease-free for extended periods of time [abstract]. Blood 2001, 98:166a.

4. Powles R, Sirohi B, Treleaven J, et al.: Continued first complete remission in multiple myeloma for over 10 years: a series of “operationally cured” patients [abstract]. Blood 2000, 96(Suppl 1):515a.

5. Zomas A, Dimopoulos MA: Conventional treatment of myeloma. In Myeloma. Edited by Mehta J, Singhal S. London: Martin Dunitz; 2002:313–326.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second- and third-line treatment strategies in multiple myeloma: a referral-center experience;Blood Cancer Journal;2022-12-06

2. Second and Third Line Treatment Strategies in Multiple Myeloma: a Referral-Center Experience;2022-09-06

3. How I treat elderly patients with myeloma;Blood;2010-09-30

4. Lenalidomide in Myeloma;Current Treatment Options in Oncology;2007-08-23

5. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years;Bone Marrow Transplantation;2007-08-06